ArticleVaccine2023

Anti-SARS-CoV-2 cellular response after 2 and 3 doses of BNT162b2 mRNA vaccine in lymphoma patients receiving anti-CD20 antibodies.

Simon B Gressens et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.